Surgery Non Current Liabilities Total from 2010 to 2024

SGRY Stock  USD 22.89  0.52  2.22%   
Surgery Partners Non Current Liabilities Total yearly trend continues to be fairly stable with very little volatility. Non Current Liabilities Total will likely drop to about 2.6 B in 2024. During the period from 2010 to 2024, Surgery Partners Non Current Liabilities Total regression line of annual values had r-squared of  0.80 and arithmetic mean of  1,985,517,967. View All Fundamentals
 
Non Current Liabilities Total  
First Reported
2014-12-31
Previous Quarter
3.3 B
Current Value
5.1 B
Quarterly Volatility
874.2 M
 
Yuan Drop
 
Covid
Check Surgery Partners financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Surgery Partners' main balance sheet or income statement drivers, such as Depreciation And Amortization of 80.6 M, Interest Expense of 148.4 M or Selling General Administrative of 80.8 M, as well as many indicators such as Price To Sales Ratio of 1.52, Dividend Yield of 0.0014 or PTB Ratio of 2.12. Surgery financial statements analysis is a perfect complement when working with Surgery Partners Valuation or Volatility modules.
  
Check out the analysis of Surgery Partners Correlation against competitors.
For more information on how to buy Surgery Stock please use our How to Invest in Surgery Partners guide.

Latest Surgery Partners' Non Current Liabilities Total Growth Pattern

Below is the plot of the Non Current Liabilities Total of Surgery Partners over the last few years. It is Surgery Partners' Non Current Liabilities Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Surgery Partners' overall financial position and show how it may be relating to other accounts over time.
Non Current Liabilities Total10 Years Trend
Slightly volatile
   Non Current Liabilities Total   
       Timeline  

Surgery Non Current Liabilities Total Regression Statistics

Arithmetic Mean1,985,517,967
Geometric Mean1,552,278,394
Coefficient Of Variation56.76
Mean Deviation1,007,975,702
Median2,542,085,000
Standard Deviation1,126,952,057
Sample Variance1270020.9T
Range2.8B
R-Value0.89
Mean Square Error278190.2T
R-Squared0.80
Slope224,911,252
Total Sum of Squares17780293.1T

Surgery Non Current Liabilities Total History

20242.6 B
2023B
20222.9 B
20213.3 B
20203.2 B
20192.9 B
20182.5 B

About Surgery Partners Financial Statements

Surgery Partners investors use historical fundamental indicators, such as Surgery Partners' Non Current Liabilities Total, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Surgery Partners. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Non Current Liabilities TotalB2.6 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Surgery Stock Analysis

When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.